Atlas Trials

Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT00004654 · COMPLETED

Trial details

NCT number
NCT00004654
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hereditary Hemorrhagic Telangiectasia
Start date
1996-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.